---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-24-000081"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T20:15:34.016223+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific approves 2025 bonus plan and two performance share programs

## Summary
- 2025 Annual Bonus Plan: target bonus pool with payout 0%-150% based on global sales, adjusted EPS, operating income and ESG goals.
- 2025 rTSR PSP: awards 0%-200% of target based on TSR vs S&P 500 Healthcare Index over 2025-2027.
- 2025 Organic Net Sales PSP: awards 0%-200% of target based on organic net sales growth vs financial plan over 2025-2027.
- Awards subject to Dodd-Frank clawback policy and discretionary recoupment for executive misconduct or harm.
- Retirement eligibility requires age 55, 5 years service, sum ≥65; retirement before Jan 1, 2026 forfeits performance shares.

## SEC filing metadata
- accession: 0000885725-24-000081
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572524000081/0000885725-24-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572524000081/bsx-20241119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-24-000081
- JSON: https://secwatch.observer/filing/0000885725-24-000081.json
- Plain text: https://secwatch.observer/filing/0000885725-24-000081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.